| (INR) | Sep 2020 | Y/Y change |
|---|---|---|
| Revenue | 1.26B | — |
| Operating expense | — | — |
| Net income | 209.12M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, LINCOLN.NS returned +12.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.6% |
| 1 year | +12.8% |
| 5 years | +87.9% |
| 10 years | +182.7% |
| All-time high | ₹787.80 (Dec 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in LINCOLN.NS would be worth today ›Yes. Lincoln Pharmaceuticals Limited paid 1 dividend over the past 12 months. The most recent was ₹1.80 per share on Sep 12, 2025. The dividend yield is 0.29%.
Lincoln Pharmaceuticals Limited is part of the Healthcare sector.
Lincoln Pharmaceuticals Limited has a market cap of 12.28B INR, based on the latest quote.
